AbbVie Inc.ABBVNYSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR+36.8%
5Y CAGR-6.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+36.8%/yr
vs -7.8%/yr prior
5Y CAGR
-6.4%/yr
Recent acceleration
Acceleration
+44.5pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.34% |
| Q3 2025 | 2.29% |
| Q2 2025 | 15.59% |
| Q1 2025 | -11.65% |
| Q4 2024 | 4.44% |
| Q3 2024 | -0.01% |
| Q2 2024 | 17.48% |
| Q1 2024 | -13.92% |
| Q4 2023 | 2.69% |
| Q3 2023 | 0.45% |
| Q2 2023 | 13.42% |
| Q1 2023 | -19.15% |
| Q4 2022 | 2.09% |
| Q3 2022 | 1.57% |
| Q2 2022 | 7.72% |
| Q1 2022 | -9.06% |
| Q4 2021 | 3.79% |
| Q3 2021 | 2.74% |
| Q2 2021 | 7.29% |
| Q1 2021 | -6.12% |
| Q4 2020 | 7.41% |
| Q3 2020 | 23.76% |
| Q2 2020 | 20.95% |
| Q1 2020 | -0.98% |
| Q4 2019 | 2.65% |
| Q3 2019 | 2.71% |
| Q2 2019 | 5.45% |
| Q1 2019 | -5.74% |
| Q4 2018 | 0.84% |
| Q3 2018 | -0.51% |
| Q2 2018 | 4.34% |
| Q1 2018 | 2.52% |
| Q4 2017 | 10.64% |
| Q3 2017 | 0.73% |
| Q2 2017 | 6.21% |
| Q1 2017 | -3.80% |
| Q4 2016 | 5.66% |
| Q3 2016 | -0.31% |
| Q2 2016 | 8.29% |
| Q1 2016 | -6.91% |